Jump to Main Content
HIV-1 Integrase and Neuraminidase Inhibitors from Alpinia zerumbet
- Upadhyay, Atul, Chompoo, Jamnian, Kishimoto, Wataru, Makise, Tadahirio, Tawata, Shinkichi
- Journal of agricultural and food chemistry 2011 v.59 no.7 pp. 2857–2862
- Alpinia zerumbet, Human immunodeficiency virus 1, acquired immunodeficiency syndrome, bioactive properties, disease resistance, drugs, economics, enzyme inhibition, humans, influenza, inhibitory concentration 50, leaves, rhizomes, sialidase, Ryukyu Archipelago
- AIDS and influenza are viral pandemics and remain one of the leading causes of human deaths worldwide. The increasing resistance of these diseases to synthetic drugs demands the search for novel compounds from plant-based sources. In this regard, the leaves and rhizomes of Alpinia zerumbet, a traditionally important economic plant in Okinawa, were investigated for activity against HIV-1 integrase (IN) and neuraminidase (NA). The aqueous extracts of leaves and rhizomes had IN inhibitory activity with IC50 values of 30 and 188 μg/mL, whereas against NA they showed 50% inhibition at concentrations of 43 and 57 μg/mL, respectively. 5,6-Dehydrokawain (DK), dihydro-5,6-dehydrokawain (DDK), and 8(17),12-labdadiene-15,16-dial (labdadiene) were isolated from the rhizomes and were tested for enzyme inhibitions. DK and DDK strongly inhibited IN with IC50 of 4.4 and 3.6 μg/mL, respectively. Against NA, DK, DDK, and labdadiene exhibited mixed type of inhibition with respective IC50 values of 25.5, 24.6, and 36.6 μM and K(i) values ranging from 0.3 to 2.8 μM. It was found that DDK is a slow and time-dependent reversible inhibitor of NA, probably with a methoxy group as its functionally active site. These results suggest that alpinia could be used as a source of bioactive compounds against IN and NA and that DK and DDK may have possibilities in the design of drugs against these viral diseases.